
Standard BioTools Investor Relations Material
Latest events

Q1 2025
Standard BioTools
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Standard BioTools Inc
Access all reports
Standard BioTools Inc. (formerly known as Fluidigm Corporation) is a life sciences technology company that provides advanced tools and systems for biological research. The company specializes in products for mass cytometry, genomics, and other high-throughput techniques that enable researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Standard BioTools' solutions support research in areas such as cancer, immunology, and drug discovery. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Standard BioTools Inc


Jefferies London Healthcare Conference 2024
Standard BioTools Inc


Q1 2025
Standard BioTools Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
LAB
Country
🇺🇸 United States